GlassScriptPhysician profile
Holly Patton
NPI 1457933590
$1,695.04
in general payments reported to CMS, 2019-2025
18 companies · $835 in 2025
The $835 reported for 2025 was more than what 82% of Nurse Practitioner providers received nationally (typical 2025 total: $174).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2023: $403 · 2024: $458 · 2025: $835.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,695.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,695.04 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $360.36 | 2023-2025 | Farxiga, Breztri, Airsupra |
| Abbvie INC. | $262.01 | 2024-2025 | |
| Otsuka America Pharmaceutical, INC. | $237.83 | 2023-2025 | Rexulti |
| Novo Nordisk INC | $235.65 | 2023-2025 | Ozempic, Rybelsus, Wegovy |
| Vanda Pharmaceuticals INC. | $114.33 | 2025 | Fanapt |
| Lundbeck LLC | $113.53 | 2024-2025 | Rexulti |
| Amgen INC. | $63.18 | 2023-2025 | Repatha, Otezla, Repatha |
| Glaxosmithkline, LLC. | $58.38 | 2023-2025 | Trelegy Ellipta |
| Sumitomo Pharma America, INC. | $46.06 | 2024-2025 | Gemtesa |
| Axsome Therapeutics, INC. | $38.84 | 2025 | Auvelity |
| Pfizer INC. | $29.80 | 2023 | |
| Dexcom, INC. | $28.38 | 2025 | Dexcom G6 Transmitter |
| Tris Pharma INC | $23.15 | 2025 | Dyanavel Xr |
| Collegium Pharmaceutical, INC. | $22.48 | 2024 | Belbuca |
| Boehringer Ingelheim Pharmaceuticals, INC. | $17.16 | 2025 | Jardiance |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Iti, INC. (D/B/A Intra-Cellular Therapies, INC.) | $14.84 | 2025 | Caplyta |
| Lilly USA, LLC | $14.61 | 2023 | Emgality, Jardiance |
| Exact Sciences Corporation | $14.45 | 2025 | Cologuard Collection Kit |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Holly Patton listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.